₹1,198.75 3.75 (0.31%)
4-Oct-2024₹1,199.85 5.60 (0.47%)
4-Oct-2024BSE : 543064
NSE : SUVENPHAR
Sector : Health care
ISIN Code : INE03QK01018
Last Updated: 04-Oct-2024
Market Cap (₹ Cr) | 30,520 |
Traded Value (₹ Cr) | 0.59 |
Volume (Shares) | 4,935 |
Face Value (₹) | 1 |
52-Week High (₹) | 1,289.30 |
52-Week High Date | 23-Sep-2024 |
52-Week Low (₹) | 542.35 |
52-Week Low Date | 10-Nov-2023 |
All Time High (₹) | 1,289.30 |
All Time High Date | 23-Sep-2024 |
All Time Low (₹) | 87.05 |
All Time Low Date | 24-Mar-2020 |
PARAMETER | VALUES |
---|---|
Market Cap (₹ Cr) | 30,548 |
EPS - TTM (₹) [C] | 9.45 |
P/E Ratio (X) [C] | 126.97 |
Face Value (₹) | 1 |
Latest Dividend (%) | 100.00 |
Latest Dividend Date | 09-Sep-2022 |
Dividend Yield (%) | - |
Book Value Share (₹) [C] | 80.56 |
P/B Ratio (₹) [C] | 14.89 |
Scheme Name | Amount Invested (₹ Cr) | No Of Shares | Net Asset (%) |
---|---|---|---|
JM Flexicap Fund (G) | 56.02 | 4,77,549 | 1.24 |
JM Flexicap Fund (IDCW) | 56.02 | 4,77,549 | 1.24 |
JM Flexicap Fund - Direct (IDCW) | 56.02 | 4,77,549 | 1.24 |
JM Flexicap Fund - Direct (G) | 56.02 | 4,77,549 | 1.24 |
JM Value Fund (G) | 21.97 | 1,87,307 | 2.03 |
JM Value Fund (IDCW) | 21.97 | 1,87,307 | 2.03 |
JM Value Fund - Direct (IDCW) | 21.97 | 1,87,307 | 2.03 |
JM Value Fund - Direct (G) | 21.97 | 1,87,307 | 2.03 |
JM Aggressive Hybrid Fund - Direct (IDCW-Annual) | 10.94 | 93,248 | 1.70 |
JM Aggressive Hybrid Fund - (IDCW) | 10.94 | 93,248 | 1.70 |
Load more
Date | Broker | Action | Prices(₹) | Report |
---|---|---|---|---|
Data Not Found |
Today's Low/High (₹) | 1,165.00 1,209.75 |
Week Low/High (₹) | 1,151.05 1,217.00 |
Month Low/High (₹) | 1,075.00 1,288.00 |
Year Low/High (₹) | 541.00 1,288.00 |
All time Low/High (₹) | 87.05 1,288.00 |
Period | BSE | NSE | SENSEX | NIFTY |
---|---|---|---|---|
1 Week | 3.48% | 3.54% | -4.54 | -4.45% |
1 Month | 6.88% | 6.30% | -0.81 | -0.73% |
3 Month | 47.24% | 47.38% | 2.05 | 2.93% |
6 Month | 86.24% | 85.85% | 10.05 | 11.10% |
1 Year | 111.86% | 111.58% | 25.24 | 28.70% |
3 Year | 123.77% | 123.50% | 37.76 | 41.40% |
Non Executive Director : Shweta Jalan
Independent Director : U B Pravin Rao
Managing Director : Venkatanaga Kali Vara Prasad Raju Vetukuri
Non Executive Director : Pankaj Patwari
Independent Director : Matangi Gowrishankar
Independent Director : Vinod Rao
Independent Director : K G Ananthakrishnan
Executive Chairman & Director : VIVEK SHARMA
Company Sec. & Compli. Officer : Kundan Kumar Jha
Registered Office: 8-2-334 SDE Serene Chambers, 3 Floor Avenue 7 Road No 5,Hyderabad,Telangana-500034 Ph: 91-40-23549414/1142/3311
Email:khrao@suvenpharm.com
1. What's the Suven Pharmaceuticals Ltd share price today?
Suven Pharmaceuticals Ltd share price was Rs 1,198.75 at close on 4th Oct 2024. Suven Pharmaceuticals Ltd share price was up by 0.31% over the previous closing price of Rs 1,195.00. Suven Pharmaceuticals Ltd share price trend:
2. How can I quickly analyse the performance of the Suven Pharmaceuticals Ltd stock?
The performance of the Suven Pharmaceuticals Ltd stock can be quickly analysed on the following metrics:
3. What is the market cap of Suven Pharmaceuticals Ltd?
Suven Pharmaceuticals Ltd has a market capitalisation of Rs 30,520 crore.
4. What is Suven Pharmaceuticals Ltd's 52-week high/low share price?
The Suven Pharmaceuticals Ltd’s 52-week high share price is Rs 1,289.30 and 52-week low share price is Rs 542.35.
5. Is the Suven Pharmaceuticals Ltd profitable?
On a consolidated basis, Suven Pharmaceuticals Ltd reported a profit of Rs 65.08 crore on a total income of Rs 240.04 crore for the quarter ended 2024. For the year ended Jun 2024, Suven Pharmaceuticals Ltd had posted a profit of Rs 65.08 crore on a total income of Rs 240.04 crore.
6. Which are Suven Pharmaceuticals Ltd’s peers in the Health care sector?
Suven Pharmaceuticals Ltd’s top 5 peers in the Health care sector are Biocon, Ajanta Pharma, Ipca Labs., Suven Pharma, Piramal Pharma, Gland Pharma, Emcure Pharma.
7. Who owns how much in Suven Pharmaceuticals Ltd?
Key changes to the Suven Pharmaceuticals Ltd shareholding are as follows: